"sample_name"	"alt_sample_name"	"sample_type"	"primarysite"	"summarygrade"	"G"	"summarystage"	"T"	"N"	"M"	"age_at_initial_pathologic_diagnosis"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"os_binary"	"relapse_binary"	"family_history"	"msi"	"location"	"summarylocation"	"gender"	"kras"	"braf"	"line1"	"tumor_size"	"mss"	"mutation_apc"	"lymphnodesremoved"	"lymphnodesinvaded"	"stageall"	"ethnicity"	"dfs_status"	"days_to_recurrence_or_death"	"batch_1"	"batch_2"	"batch_3"	"drug_name"	"drug_treatment"	"drug_response"	"uncurated_author_metadata"
"GSM712195"	"colorectal cancer sample C1018II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1018II [exon-level]///geo_accession: GSM712195///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712195/GSM712195_C1018II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712082 (gene-level analysis)"
"GSM712196"	"colorectal cancer sample C1022II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1022II [exon-level]///geo_accession: GSM712196///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712196/GSM712196_C1022II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712083 (gene-level analysis)"
"GSM712197"	"colorectal cancer sample C1030II_2 [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1030II_2 [exon-level]///geo_accession: GSM712197///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712197/GSM712197_C1030II_HuEx-1_0-st-v2_2.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712084 (gene-level analysis)"
"GSM712198"	"colorectal cancer sample C1033III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1033III [exon-level]///geo_accession: GSM712198///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.17///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712198/GSM712198_C1033III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712085 (gene-level analysis)"
"GSM712199"	"colorectal cancer sample C1034III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1034III [exon-level]///geo_accession: GSM712199///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.17///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712199/GSM712199_C1034III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712086 (gene-level analysis)"
"GSM712200"	"colorectal cancer sample C1043II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1043II [exon-level]///geo_accession: GSM712200///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712200/GSM712200_C1043II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712087 (gene-level analysis)"
"GSM712201"	"colorectal cancer sample C1049II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1049II [exon-level]///geo_accession: GSM712201///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.33///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712201/GSM712201_C1049II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712088 (gene-level analysis)"
"GSM712202"	"colorectal cancer sample C1065III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1065III [exon-level]///geo_accession: GSM712202///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.61///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712202/GSM712202_C1065III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712089 (gene-level analysis)"
"GSM712203"	"colorectal cancer sample C1068III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1068III [exon-level]///geo_accession: GSM712203///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.83///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712203/GSM712203_C1068III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712090 (gene-level analysis)"
"GSM712204"	"colorectal cancer sample C1077III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1077III [exon-level]///geo_accession: GSM712204///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712204/GSM712204_C1077III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712091 (gene-level analysis)"
"GSM712205"	"colorectal cancer sample C1085II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1085II [exon-level]///geo_accession: GSM712205///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712205/GSM712205_C1085II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712092 (gene-level analysis)"
"GSM712206"	"colorectal cancer sample C1089II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1089II [exon-level]///geo_accession: GSM712206///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.25///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712206/GSM712206_C1089II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712093 (gene-level analysis)"
"GSM712207"	"colorectal cancer sample C1091II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1091II [exon-level]///geo_accession: GSM712207///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 2.25///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712207/GSM712207_C1091II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712094 (gene-level analysis)"
"GSM712208"	"colorectal cancer sample C1102II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1102II [exon-level]///geo_accession: GSM712208///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.33///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712208/GSM712208_C1102II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712095 (gene-level analysis)"
"GSM712209"	"colorectal cancer sample C1112II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1112II [exon-level]///geo_accession: GSM712209///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712209/GSM712209_C1112II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712096 (gene-level analysis)"
"GSM712210"	"colorectal cancer sample C1118III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1118III [exon-level]///geo_accession: GSM712210///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712210/GSM712210_C1118III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712097 (gene-level analysis)"
"GSM712211"	"colorectal cancer sample C1135II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1135II [exon-level]///geo_accession: GSM712211///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712211/GSM712211_C1135II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712098 (gene-level analysis)"
"GSM712212"	"colorectal cancer sample C1142III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1142III [exon-level]///geo_accession: GSM712212///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.42///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712212/GSM712212_C1142III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712099 (gene-level analysis)"
"GSM712213"	"colorectal cancer sample C1144III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1144III [exon-level]///geo_accession: GSM712213///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.67///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712213/GSM712213_C1144III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712100 (gene-level analysis)"
"GSM712214"	"colorectal cancer sample C1145III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1145III [exon-level]///geo_accession: GSM712214///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.42///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712214/GSM712214_C1145III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712101 (gene-level analysis)"
"GSM712215"	"colorectal cancer sample C1152III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1152III [exon-level]///geo_accession: GSM712215///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712215/GSM712215_C1152III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712102 (gene-level analysis)"
"GSM712216"	"colorectal cancer sample C1156II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1156II [exon-level]///geo_accession: GSM712216///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712216/GSM712216_C1156II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712103 (gene-level analysis)"
"GSM712218"	"colorectal cancer sample C1159III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1159III [exon-level]///geo_accession: GSM712218///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.67///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712218/GSM712218_C1159III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712104 (gene-level analysis)"
"GSM712221"	"colorectal cancer sample C1190II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1190II [exon-level]///geo_accession: GSM712221///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712221/GSM712221_C1190II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712105 (gene-level analysis)"
"GSM712224"	"colorectal cancer sample C1198III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1198III [exon-level]///geo_accession: GSM712224///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712224/GSM712224_C1198III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712106 (gene-level analysis)"
"GSM712226"	"colorectal cancer sample C1251III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1251III [exon-level]///geo_accession: GSM712226///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712226/GSM712226_C1251III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712107 (gene-level analysis)"
"GSM712228"	"colorectal cancer sample C1257II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1257II [exon-level]///geo_accession: GSM712228///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712228/GSM712228_C1257II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712108 (gene-level analysis)"
"GSM712231"	"colorectal cancer sample C1263II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1263II [exon-level]///geo_accession: GSM712231///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712231/GSM712231_C1263II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712109 (gene-level analysis)"
"GSM712234"	"colorectal cancer sample C1264II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1264II [exon-level]///geo_accession: GSM712234///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 6.56///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712234/GSM712234_C1264II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712110 (gene-level analysis)"
"GSM712237"	"colorectal cancer sample C1267III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1267III [exon-level]///geo_accession: GSM712237///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712237/GSM712237_C1267III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712111 (gene-level analysis)"
"GSM712238"	"colorectal cancer sample C1271III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1271III [exon-level]///geo_accession: GSM712238///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.75///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712238/GSM712238_C1271III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712112 (gene-level analysis)"
"GSM712241"	"colorectal cancer sample C1273II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1273II [exon-level]///geo_accession: GSM712241///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 7.69///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712241/GSM712241_C1273II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712113 (gene-level analysis)"
"GSM712243"	"colorectal cancer sample C1275III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1275III [exon-level]///geo_accession: GSM712243///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712243/GSM712243_C1275III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712114 (gene-level analysis)"
"GSM712245"	"colorectal cancer sample C1280III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1280III [exon-level]///geo_accession: GSM712245///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.42///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712245/GSM712245_C1280III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712115 (gene-level analysis)"
"GSM712248"	"colorectal cancer sample C1283II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1283II [exon-level]///geo_accession: GSM712248///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712248/GSM712248_C1283II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712116 (gene-level analysis)"
"GSM712251"	"colorectal cancer sample C1284III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1284III [exon-level]///geo_accession: GSM712251///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712251/GSM712251_C1284III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712117 (gene-level analysis)"
"GSM712253"	"colorectal cancer sample C1285III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1285III [exon-level]///geo_accession: GSM712253///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.42///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712253/GSM712253_C1285III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712118 (gene-level analysis)"
"GSM712255"	"colorectal cancer sample C1286III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1286III [exon-level]///geo_accession: GSM712255///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712255/GSM712255_C1286III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712119 (gene-level analysis)"
"GSM712257"	"colorectal cancer sample C1291II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1291II [exon-level]///geo_accession: GSM712257///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712257/GSM712257_C1291II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712120 (gene-level analysis)"
"GSM712258"	"colorectal cancer sample C1292III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1292III [exon-level]///geo_accession: GSM712258///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712258/GSM712258_C1292III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712121 (gene-level analysis)"
"GSM712259"	"colorectal cancer sample C1294II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1294II [exon-level]///geo_accession: GSM712259///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712259/GSM712259_C1294II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712122 (gene-level analysis)"
"GSM712260"	"colorectal cancer sample C1296II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1296II [exon-level]///geo_accession: GSM712260///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.42///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712260/GSM712260_C1296II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712123 (gene-level analysis)"
"GSM712261"	"colorectal cancer sample C1301III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1301III [exon-level]///geo_accession: GSM712261///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712261/GSM712261_C1301III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712124 (gene-level analysis)"
"GSM712262"	"colorectal cancer sample C1308III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1308III [exon-level]///geo_accession: GSM712262///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712262/GSM712262_C1308III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712125 (gene-level analysis)"
"GSM712263"	"colorectal cancer sample C1314III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1314III [exon-level]///geo_accession: GSM712263///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.67///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712263/GSM712263_C1314III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712126 (gene-level analysis)"
"GSM712264"	"colorectal cancer sample C1321II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1321II [exon-level]///geo_accession: GSM712264///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.92///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712264/GSM712264_C1321II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712127 (gene-level analysis)"
"GSM712265"	"colorectal cancer sample C1323III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1323III [exon-level]///geo_accession: GSM712265///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.75///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712265/GSM712265_C1323III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712128 (gene-level analysis)"
"GSM712266"	"colorectal cancer sample C1330III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1330III [exon-level]///geo_accession: GSM712266///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712266/GSM712266_C1330III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712129 (gene-level analysis)"
"GSM712267"	"colorectal cancer sample C1333III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1333III [exon-level]///geo_accession: GSM712267///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 5.5///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712267/GSM712267_C1333III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712130 (gene-level analysis)"
"GSM712268"	"colorectal cancer sample C1334III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1334III [exon-level]///geo_accession: GSM712268///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.08///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712268/GSM712268_C1334III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712131 (gene-level analysis)"
"GSM712269"	"colorectal cancer sample C1340III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1340III [exon-level]///geo_accession: GSM712269///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712269/GSM712269_C1340III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712132 (gene-level analysis)"
"GSM712270"	"colorectal cancer sample C1356III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1356III [exon-level]///geo_accession: GSM712270///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712270/GSM712270_C1356III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712133 (gene-level analysis)"
"GSM712271"	"colorectal cancer sample C1357II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1357II [exon-level]///geo_accession: GSM712271///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 0.75///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712271/GSM712271_C1357II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712134 (gene-level analysis)"
"GSM712272"	"colorectal cancer sample C1364II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1364II [exon-level]///geo_accession: GSM712272///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712272/GSM712272_C1364II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712135 (gene-level analysis)"
"GSM712273"	"colorectal cancer sample C1379II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1379II [exon-level]///geo_accession: GSM712273///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.83///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712273/GSM712273_C1379II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712136 (gene-level analysis)"
"GSM712274"	"colorectal cancer sample C1380III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1380III [exon-level]///geo_accession: GSM712274///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712274/GSM712274_C1380III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712137 (gene-level analysis)"
"GSM712275"	"colorectal cancer sample C1389III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1389III [exon-level]///geo_accession: GSM712275///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.33///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712275/GSM712275_C1389III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712138 (gene-level analysis)"
"GSM712276"	"colorectal cancer sample C1391II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1391II [exon-level]///geo_accession: GSM712276///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.5///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712276/GSM712276_C1391II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712139 (gene-level analysis)"
"GSM712277"	"colorectal cancer sample C1393III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1393III [exon-level]///geo_accession: GSM712277///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.25///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712277/GSM712277_C1393III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712140 (gene-level analysis)"
"GSM712278"	"colorectal cancer sample C1395II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1395II [exon-level]///geo_accession: GSM712278///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712278/GSM712278_C1395II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712141 (gene-level analysis)"
"GSM712279"	"colorectal cancer sample C1402III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C1402III [exon-level]///geo_accession: GSM712279///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.92///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712279/GSM712279_C1402III_HuEx-1_0-st-v2_3.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712142 (gene-level analysis)"
"GSM712280"	"colorectal cancer sample C861y [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C861y [exon-level]///geo_accession: GSM712280///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712280/GSM712280_C861y_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712143 (gene-level analysis)"
"GSM712281"	"colorectal cancer sample C891II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C891II [exon-level]///geo_accession: GSM712281///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 0.33///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712281/GSM712281_C891II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712144 (gene-level analysis)"
"GSM712282"	"colorectal cancer sample C895II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C895II [exon-level]///geo_accession: GSM712282///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712282/GSM712282_C895II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712145 (gene-level analysis)"
"GSM712283"	"colorectal cancer sample C896III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C896III [exon-level]///geo_accession: GSM712283///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712283/GSM712283_C896III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712146 (gene-level analysis)"
"GSM712284"	"colorectal cancer sample C914III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C914III [exon-level]///geo_accession: GSM712284///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712284/GSM712284_C914III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712147 (gene-level analysis)"
"GSM712285"	"colorectal cancer sample C932III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C932III [exon-level]///geo_accession: GSM712285///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712285/GSM712285_C932III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712148 (gene-level analysis)"
"GSM712286"	"colorectal cancer sample C935II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C935II [exon-level]///geo_accession: GSM712286///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712286/GSM712286_C935II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712149 (gene-level analysis)"
"GSM712287"	"colorectal cancer sample C937III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C937III [exon-level]///geo_accession: GSM712287///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712287/GSM712287_C937III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712150 (gene-level analysis)"
"GSM712288"	"colorectal cancer sample C940III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C940III [exon-level]///geo_accession: GSM712288///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712288/GSM712288_C940III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712151 (gene-level analysis)"
"GSM712289"	"colorectal cancer sample C946II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C946II [exon-level]///geo_accession: GSM712289///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.75///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712289/GSM712289_C946II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712152 (gene-level analysis)"
"GSM712290"	"colorectal cancer sample C950II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C950II [exon-level]///geo_accession: GSM712290///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712290/GSM712290_C950II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712153 (gene-level analysis)"
"GSM712291"	"colorectal cancer sample C964II [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C964II [exon-level]///geo_accession: GSM712291///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.5///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712291/GSM712291_C964II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712154 (gene-level analysis)"
"GSM712292"	"colorectal cancer sample C965II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C965II [exon-level]///geo_accession: GSM712292///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712292/GSM712292_C965II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712155 (gene-level analysis)"
"GSM712293"	"colorectal cancer sample C970II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C970II [exon-level]///geo_accession: GSM712293///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712293/GSM712293_C970II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712156 (gene-level analysis)"
"GSM712294"	"colorectal cancer sample C975III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C975III [exon-level]///geo_accession: GSM712294///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.67///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712294/GSM712294_C975III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712157 (gene-level analysis)"
"GSM712295"	"colorectal cancer sample C976II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C976II [exon-level]///geo_accession: GSM712295///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712295/GSM712295_C976II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712158 (gene-level analysis)"
"GSM712296"	"colorectal cancer sample C978II [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C978II [exon-level]///geo_accession: GSM712296///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712296/GSM712296_C978II_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712159 (gene-level analysis)"
"GSM712297"	"colorectal cancer sample C980III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C980III [exon-level]///geo_accession: GSM712297///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 10///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712297/GSM712297_C980III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712160 (gene-level analysis)"
"GSM712298"	"colorectal cancer sample C981III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C981III [exon-level]///geo_accession: GSM712298///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.58///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712298/GSM712298_C981III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712161 (gene-level analysis)"
"GSM712299"	"colorectal cancer sample C982III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C982III [exon-level]///geo_accession: GSM712299///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 1.25///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712299/GSM712299_C982III_RUN2_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712162 (gene-level analysis)"
"GSM712300"	"colorectal cancer sample C983III [exon-level]"	NA	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C983III [exon-level]///geo_accession: GSM712300///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.13///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712300/GSM712300_C983III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712163 (gene-level analysis)"
"GSM712301"	"colorectal cancer sample C985III [exon-level]"	NA	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample C985III [exon-level]///geo_accession: GSM712301///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.42///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712301/GSM712301_C985III_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712164 (gene-level analysis)"
